Home
Conditions
Neurofibroma

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

238 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Neurofibroma trial results

Not yet recruiting

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

NCT07024394

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children

NCT06763315

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Not yet recruiting

Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule

NCT06620354

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule

NCT06621082

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

NCT06526897

Conditions: AJCC Grade 2 Sarcoma, AJCC Grade 3 Sarcoma, Adult Pleomorphic Rhabdomyosarcoma, +46 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Neurofibromatosis-associated Tumor Biobank

NCT03359304

Conditions: Bone Diseases, Bone Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Neurofibromatosis Type 1 Tumor Early Detection Study

NCT06515860

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +28 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Enrolling by invitation

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

NCT06603987

Conditions: Adenoma, Breast Diseases, Breast Neoplasms, +40 more
Locations: ORIX Kouraibashi Bldg. 8F 3-2-7 Kouraibashi Chuo-ku Osaka, Japan

View Trial Details

Active, not recruiting

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

NCT01362803

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +22 more
Locations: Children's National Medical Center Washington D.C., District of Columbia, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

NF-1, Nutraceutical Intervention

NCT05363267

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Neurofibroma

Neurofibroma trial results

Related conditions